Marie Devaux
Nantes, 44200, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Immune-driven gene expression loss following intramuscular AAV delivery to non-human primates is only transient.
Journal: Molecular therapy. Methods & clinical development
Published: July 22, 2024
Incomplete elimination of viral genomes is associated with chronic inflammation in nonhuman primate livers after AAV-mediated gene transfer.
Journal: Gene therapy
Published: July 04, 2024
AAV8 locoregional delivery induces long-term expression of an immunogenic transgene in macaques despite persisting local inflammation.
Journal: Molecular therapy. Methods & clinical development
Published: August 27, 2020
Tetramer-Based Enrichment of Preexisting Anti-AAV8 CD8+ T Cells in Human Donors Allows the Detection of a TEMRA Subpopulation.
Journal: Frontiers in immunology
Published: October 28, 2019
Five Years of Successful Inducible Transgene Expression Following Locoregional Adeno-Associated Virus Delivery in Nonhuman Primates with No Detectable Immunity.
Journal: Human gene therapy
Published: February 28, 2019
Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy.
Journal: Nature communications
Published: August 18, 2016
Transgene regulation using the tetracycline-inducible TetR-KRAB system after AAV-mediated gene transfer in rodents and nonhuman primates.
Journal: PloS one
Published: March 05, 2014
Forelimb treatment in a large cohort of dystrophic dogs supports delivery of a recombinant AAV for exon skipping in Duchenne patients.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 28, 2014
Generation and in vivo evaluation of IL10-treated dendritic cells in a nonhuman primate model of AAV-based gene transfer.
Journal: Molecular therapy. Methods & clinical development
Published: January 01, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026